S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$15.14
-5.4%
$17.55
$8.92
$24.50
$685.84M1.67402,842 shs313,436 shs
Cutera, Inc. stock logo
CUTR
Cutera
$2.38
+18.4%
$2.12
$1.28
$24.58
$47.46M1.661.73 million shs1.53 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$87.86
-5.8%
$83.01
$36.42
$99.63
$2.87B1.99688,928 shs997,596 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-5.38%-12.28%-10.94%-11.10%-23.15%
Cutera, Inc. stock logo
CUTR
Cutera
+18.41%+36.00%+30.05%-21.32%-90.23%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-5.84%-8.14%+18.47%+9.46%+23.42%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
1.6762 of 5 stars
3.51.00.00.02.12.50.6
Cutera, Inc. stock logo
CUTR
Cutera
0.7153 of 5 stars
3.31.00.00.00.01.70.6
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
0.755 of 5 stars
2.41.00.00.01.82.50.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
3.00
Buy$23.4054.56% Upside
Cutera, Inc. stock logo
CUTR
Cutera
2.50
Moderate Buy$14.75519.75% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.86
Moderate Buy$102.0016.09% Upside

Current Analyst Ratings

Latest BLFS, TMDX, and CUTR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/4/2024
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$22.00
3/28/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$95.00
3/22/2024
Cutera, Inc. stock logo
CUTR
Cutera
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$10.00
3/22/2024
Cutera, Inc. stock logo
CUTR
Cutera
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Market Perform
3/6/2024
Cutera, Inc. stock logo
CUTR
Cutera
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$10.00
2/28/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$75.00 ➝ $95.00
2/27/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$87.00 ➝ $105.00
2/27/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$92.00 ➝ $105.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$143.27M4.79N/AN/A$7.67 per share1.97
Cutera, Inc. stock logo
CUTR
Cutera
$212.37M0.22N/AN/A($8.01) per share-0.30
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$241.62M11.90$0.14 per share645.09$4.20 per share20.92

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$66.43M-$1.52N/AN/AN/A-46.37%-13.36%-10.83%5/8/2024 (Estimated)
Cutera, Inc. stock logo
CUTR
Cutera
-$150.83M-$7.34N/AN/AN/A-68.87%N/A-34.04%5/14/2024 (Estimated)
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-$25.03M-$0.77N/A214.29N/A-10.36%-2.35%-0.60%4/30/2024 (Confirmed)

Latest BLFS, TMDX, and CUTR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024N/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-$0.05N/A+$0.05N/AN/AN/A  
3/21/2024Q4 2023
Cutera, Inc. stock logo
CUTR
Cutera
-$1.20-$2.27-$1.07-$2.27$49.10 million$49.54 million
3/5/2024Q3 2023
Cutera, Inc. stock logo
CUTR
Cutera
N/A-$2.22-$2.22-$2.22N/A$46.48 million
2/29/2024Q4 2023
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$0.24-$0.22+$0.02-$0.14$32.70 million$32.73 million
2/26/2024Q4 2023
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-$0.10$0.12+$0.22$0.12$68.49 million$81.20 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
0.06
2.86
1.83
Cutera, Inc. stock logo
CUTR
Cutera
N/A
3.17
2.44
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
3.69
9.30
8.49

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
Cutera, Inc. stock logo
CUTR
Cutera
90.70%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.70%
Cutera, Inc. stock logo
CUTR
Cutera
2.90%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
6.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
40945.30 million44.08 millionOptionable
Cutera, Inc. stock logo
CUTR
Cutera
54019.94 million19.37 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
58432.71 million30.52 millionOptionable

BLFS, TMDX, and CUTR Headlines

SourceHeadline
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Rating of "Moderate Buy" from BrokeragesTransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Rating of "Moderate Buy" from Brokerages
americanbankingnews.com - April 18 at 2:32 AM
TransMedics Group (NASDAQ:TMDX) Stock Price Down 6.1%TransMedics Group (NASDAQ:TMDX) Stock Price Down 6.1%
marketbeat.com - April 17 at 2:16 PM
Validea Detailed Fundamental Analysis - TMDXValidea Detailed Fundamental Analysis - TMDX
nasdaq.com - April 17 at 8:57 AM
TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024
finance.yahoo.com - April 16 at 8:10 PM
TransMedics (TMDX) Flat As Market Sinks: What You Should KnowTransMedics (TMDX) Flat As Market Sinks: What You Should Know
zacks.com - April 15 at 7:21 PM
Theres Been No Shortage Of Growth Recently For TransMedics Groups (NASDAQ:TMDX) Returns On CapitalThere's Been No Shortage Of Growth Recently For TransMedics Group's (NASDAQ:TMDX) Returns On Capital
finance.yahoo.com - April 15 at 2:13 PM
Insider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) CEO Sells 12,000 Shares of StockInsider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) CEO Sells 12,000 Shares of Stock
insidertrades.com - April 14 at 4:20 AM
TransMedics Group, Inc. (NASDAQ:TMDX) CEO Sells $1,141,080.00 in StockTransMedics Group, Inc. (NASDAQ:TMDX) CEO Sells $1,141,080.00 in Stock
marketbeat.com - April 12 at 6:32 PM
Wall Street Favorites: 3 Long-Term Stocks With Strong Buy Ratings for April 2024Wall Street Favorites: 3 Long-Term Stocks With Strong Buy Ratings for April 2024
investorplace.com - April 12 at 4:30 PM
TransMedics group exec sells over $1.79 million in company stockTransMedics group exec sells over $1.79 million in company stock
investing.com - April 12 at 9:43 AM
3 Must-Own Stocks for Sustained Growth Over the Next 18 Months3 Must-Own Stocks for Sustained Growth Over the Next 18 Months
investorplace.com - April 12 at 6:30 AM
Tamer I. Khayal Sells 15,512 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) StockTamer I. Khayal Sells 15,512 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) Stock
americanbankingnews.com - April 12 at 4:36 AM
The 3 Most Promising MedTech Stocks to Invest In NowThe 3 Most Promising MedTech Stocks to Invest In Now
investorplace.com - April 11 at 2:55 PM
Heart And Lung Transplants Drive Medical Stock Higher As S&P 500 FizzlesHeart And Lung Transplants Drive Medical Stock Higher As S&P 500 Fizzles
finance.yahoo.com - April 11 at 2:12 PM
Organ Transplant Stock Surges Past Buy Point Even As S&P 500 FizzlesOrgan Transplant Stock Surges Past Buy Point Even As S&P 500 Fizzles
investors.com - April 11 at 10:55 AM
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Peregrine Capital Management LLCTransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Peregrine Capital Management LLC
marketbeat.com - April 11 at 7:49 AM
Insider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) Insider Sells 15,512 Shares of StockInsider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) Insider Sells 15,512 Shares of Stock
insidertrades.com - April 11 at 6:37 AM
TransMedics Group (NASDAQ:TMDX) Trading Up 2%TransMedics Group (NASDAQ:TMDX) Trading Up 2%
marketbeat.com - April 10 at 2:51 PM
Moody Aldrich Partners LLC Buys 24,290 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)Moody Aldrich Partners LLC Buys 24,290 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)
marketbeat.com - April 9 at 1:32 PM
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
prnewswire.com - April 8 at 4:05 PM
Kent Lake Capital LLC Has $4.34 Million Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX)Kent Lake Capital LLC Has $4.34 Million Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX)
marketbeat.com - April 6 at 7:36 PM
TransMedics Group, Inc. (NASDAQ:TMDX) Insider Sells $397,540.92 in StockTransMedics Group, Inc. (NASDAQ:TMDX) Insider Sells $397,540.92 in Stock
insidertrades.com - April 6 at 7:39 AM
TransMedics Group, Inc. (NASDAQ:TMDX) Insider Tamer I. Khayal Sells 4,947 SharesTransMedics Group, Inc. (NASDAQ:TMDX) Insider Tamer I. Khayal Sells 4,947 Shares
marketbeat.com - April 5 at 6:39 PM
Vanguard Group Inc. Grows Stake in TransMedics Group, Inc. (NASDAQ:TMDX)Vanguard Group Inc. Grows Stake in TransMedics Group, Inc. (NASDAQ:TMDX)
marketbeat.com - April 5 at 4:07 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BioLife Solutions logo

BioLife Solutions

NASDAQ:BLFS
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Cutera logo

Cutera

NASDAQ:CUTR
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
TransMedics Group logo

TransMedics Group

NASDAQ:TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.